ESC Premium Access

Non-invasive predictors of LV biopsy-obtained creatine kinase activity in patients with non-failing and failing myocardial hypertrophy

Congress Presentation

About the speaker

Doctor Mark Andrew Peterzan

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

11 more presentations in this session

Glutamine-fructose-6-phosphate amidotransferase 2 mediates isoproterenol-induced cardiac hypertrophy by increasing Akt O-GlcNAcylation through hexosamine biosynthesis pathway

Speaker: Doctor A. Ishikita (Fukuoka, JP)

Thumbnail

Epigenetic modifications via histone acetylation by p300 are changed during the transition from cardiac hypertrophy to heart failure

Speaker: Mr Y. Sunagawa (Shizuoka, JP)

Thumbnail

Inhibition of GATA4 dimerization suppress hypertrophic responses

Speaker: Mr S. Shimizu (Shizuoka, JP)

Thumbnail

Adverse left ventricular remodeling in descending thoracic vs ascending aorta banding in novel porcin model. cMRI study

Speaker: Doctor S. Popevska (Leuven, BE)

Thumbnail

The genetic background of the disease in a group of patients with severe course of hypertrophic cardiomyopathy.

Speaker: Doctor M. Klopotowski (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 2 - Cardiac hypertrophy

Speakers: Doctor M. Peterzan, Doctor A. Ishikita, Mr Y. Sunagawa, Mr S. Shimizu, Doctor S. Popevska...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb